Celgene Corporation Company Profile
✉ Email this page to a colleague
Biologic Drugs for Celgene Corporation
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Celgene Corporation, A Bristol-myers Squibb Company | ABECMA | idecabtagene vicleucel | Injection | 125736 | 10,065,997 | 2034-04-18 | DrugPatentWatch analysis and company disclosures |
| Celgene Corporation, A Bristol-myers Squibb Company | ABECMA | idecabtagene vicleucel | Injection | 125736 | 10,100,095 | 2034-10-02 | DrugPatentWatch analysis and company disclosures |
| Celgene Corporation, A Bristol-myers Squibb Company | ABECMA | idecabtagene vicleucel | Injection | 125736 | 10,138,299 | DrugPatentWatch analysis and company disclosures | |
| Celgene Corporation, A Bristol-myers Squibb Company | ABECMA | idecabtagene vicleucel | Injection | 125736 | 10,214,586 | 2036-08-18 | DrugPatentWatch analysis and company disclosures |
| Celgene Corporation, A Bristol-myers Squibb Company | ABECMA | idecabtagene vicleucel | Injection | 125736 | 10,450,373 | 2039-04-30 | DrugPatentWatch analysis and company disclosures |
| Celgene Corporation, A Bristol-myers Squibb Company | ABECMA | idecabtagene vicleucel | Injection | 125736 | 10,544,214 | 2038-08-13 | DrugPatentWatch analysis and company disclosures |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
Similar Applicant Names
This search can help find similar names.
